MONETA, CLAUDIA
 Distribuzione geografica
Continente #
AS - Asia 810
NA - Nord America 620
EU - Europa 549
SA - Sud America 81
Continente sconosciuto - Info sul continente non disponibili 70
AF - Africa 11
OC - Oceania 2
Totale 2.143
Nazione #
US - Stati Uniti d'America 584
IT - Italia 281
SG - Singapore 171
CN - Cina 170
HK - Hong Kong 129
VN - Vietnam 127
BD - Bangladesh 83
BR - Brasile 62
DE - Germania 49
NL - Olanda 44
IN - India 42
FR - Francia 38
GB - Regno Unito 31
RU - Federazione Russa 31
FI - Finlandia 25
KR - Corea 20
CA - Canada 19
TR - Turchia 14
SE - Svezia 12
MX - Messico 11
JP - Giappone 10
PH - Filippine 8
CO - Colombia 7
AR - Argentina 6
ES - Italia 6
GR - Grecia 6
ID - Indonesia 6
IE - Irlanda 6
TW - Taiwan 6
IQ - Iraq 4
PL - Polonia 4
SA - Arabia Saudita 4
AT - Austria 3
CI - Costa d'Avorio 3
ET - Etiopia 3
IL - Israele 3
UA - Ucraina 3
AU - Australia 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PA - Panama 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AM - Armenia 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
ER - Eritrea 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
SC - Seychelles 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.074
Città #
Hong Kong 119
Ashburn 103
Singapore 78
Milan 72
Dallas 55
Santa Clara 52
San Jose 51
Ho Chi Minh City 44
Hefei 37
Hanoi 30
Beijing 25
New York 25
Los Angeles 24
Council Bluffs 22
Rome 22
Boardman 21
Frankfurt am Main 18
Munich 17
Guangzhou 14
Helsinki 14
Bengaluru 13
Chicago 12
Da Nang 11
Moscow 11
Istanbul 10
Lauterbourg 10
Southend 10
Turin 10
Chandler 9
Denver 9
Houston 9
Seoul 9
São Paulo 9
London 8
Bologna 7
Buffalo 7
Florence 7
Mumbai 7
Dublin 6
Haiphong 6
Lappeenranta 6
Mexico City 6
Nuremberg 6
Srinagar 6
Toronto 6
Bari 5
Canary Wharf 5
Fairfield 5
Kent 5
Mascalucia 5
San Francisco 5
Tokyo 5
Turku 5
Amsterdam 4
Atlanta 4
Boston 4
Cheonan 4
City of London 4
Düsseldorf 4
Ioannina 4
Jakarta 4
Madrid 4
Medellín 4
Orem 4
Trivolzio 4
Yongin-si 4
Abidjan 3
Appiano Gentile 3
Basra 3
Brooklyn 3
Cangzhou 3
Catania 3
Genoa 3
Hillsboro 3
Huzhou 3
Jacksonville 3
Jerusalem 3
Kyoto 3
Locate Varesino 3
Marseille 3
Nha Trang 3
Novi Ligure 3
Pasig 3
Redwood City 3
Seattle 3
Vienna 3
Washington 3
Wilmington 3
Addis Ababa 2
Alife 2
Antalya 2
Astana 2
Bagnacavallo 2
Bishkek 2
Biên Hòa 2
Bến Tre 2
Carrières-sur-Seine 2
Castel Maggiore 2
Changsha 2
Chattanooga 2
Totale 1.235
Nome #
Management of hypertension during Lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm 287
Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review 271
Will the autofluorescence take over inadvertent parathyroidectomy?Results from a multicentre cohort study 236
Endocrine-related adverse conditions induced by tyrosine kinase inhibitors. 197
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting 177
Changing the paradigm: lobectomy for sporadic medullary thyroid cancer 163
Thyroid cancer and endocrine disruptive chemicals: a case–control study on per-fluoroalkyl substances and other persistent organic pollutants 149
Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex 136
Impatto della dose iniziale sul trattamento con lenvatinib nel carcinoma tiroideo differenziato avanzato 123
Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism 121
Letter to the Editor: Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer 120
Clinical relevance of the thyroid differentiation score (TDS) in benign and malignant thyroid tumors 98
Physical activity and systemic treatment outcomes in advanced thyroid cancer. 29
Validation of the 2025 ATA risk stratification system in a cohort of patients with papillary thyroid carcinoma 24
Development of a sensitive plasma lenvatinib quantification method and validation in thyroid cancer patients 12
Totale 2.143
Categoria #
all - tutte 5.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202235 0 4 2 3 3 4 3 0 10 2 1 3
2022/202356 5 3 1 3 5 3 0 4 2 3 21 6
2023/2024116 10 8 0 11 36 8 8 5 2 2 16 10
2024/2025380 4 13 3 12 36 18 21 34 23 75 45 96
2025/20261.315 88 114 133 74 68 77 263 35 82 98 146 137
2026/2027202 168 34 0 0 0 0 0 0 0 0 0 0
Totale 2.143